- In the DM world, the US recorded the largest ever daily increase of 58,047 new cases, up 2% from a day earlier. Total infections now stand at 3mn.
- Florida is facing a shortage of ICU beds and in Texas the number of hospitalized patients more than doubled in the last two weeks.
- The University of Washington’s Institute for Health Metrics and Evaluation (IHME) projected deaths would reach 208,000 by 1 November 2020.
- President Trump announced the US will leave WHO effective 6 July 2021.
- In the UK, there was a 0.2% increase, amounting to 584 new cases. Chancellor Rishi Sunak announced a £2bn Kickstart Scheme targeting unemployed young people, a £1bn funding for energy efficiency improvements, a doubling of work coaches in jobcentres, and a furloughed workers retention bonus for employers. On vaccines, polling by YouGov shows 16% of British adults would refuse to vaccinate against Covid-19.
- In Sweden, the daily growth in cases was 0.4%, amounting to only 283 new infections. Case numbers have consistently declined over the past several days in contrast to last month when new daily infections were as high as 1,800.
- In EM, Brazil recorded a 2.8% increase. At 45,305, it is one of the largest daily case increases since the pandemic began. President Jair Bolsonaro tested positive for Covid-19.
- South Africa recorded 10,134 cases on Tuesday, its second largest daily increase so far.
- Argentina and Israel set new records for daily growth in cases. For the latter, however, the increase partly reflects amendments to how infected patients are categorized.
- For more perspective, we also publish our quadrant charts too.
Bilal Hafeez is the CEO and Editor of Macro Hive. He spent over twenty years doing research at big banks – JPMorgan, Deutsche Bank, and Nomura, where he had various “Global Head” roles and did FX, rates and cross-markets research.
Stefan Posea is a Research Analyst at Macro Hive. His research interests lie in macro-financial interactions and monetary policy analysis. Stefan graduated with an MSc in Economics at Birkbeck, University of London and previously held roles in M&A and the Public Sector.
(The commentary contained in the above article does not constitute an offer or a solicitation, or a recommendation to implement or liquidate an investment or to carry out any other transaction. It should not be used as a basis for any investment decision or other decision. Any investment decision should be based on appropriate professional advice specific to your needs.)